Research article
Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity
-
* Corresponding author: Sacha J Howell SHowell@picr.man.ac.uk
Breast Cancer Research 2008, 10:R68 doi:10.1186/bcr2129
No comments have yet been made on this article.